Supplier profile
ratiopharm GmbH
Every public-sector award we hold for this supplier, across Germany, from 30 Oct 2009 to 25 Jul 2026.
Awards won
297
all time
Attributed value
€2
265 shared, unvalued
Buyers
41
public bodies
Active
2009–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 72 | not attributable |
| GWQ ServicePlus AG | 27 | not attributable |
| IKK classic | 27 | not attributable |
| AOK Nordost – Die Gesundheitskasse | 22 | not attributable |
| Techniker Krankenkasse | 21 | €1 |
| Bundesamt für Ausrüstung, Informationstechnik und Nutzung der Bundeswehr | 17 | not attributable |
| Vergabestelle der AOK – Rheinland-Pfalz/Saarland – Die Gesundheitskasse | 17 | not attributable |
| AOK Bayern – Die Gesundheitskasse | 16 | not attributable |
| AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen; Stabsbereich Recht; Referat Zentrale Vergabestelle | 11 | not attributable |
| AOK Baden-Württemberg | 9 | not attributable |
What they win
Awards
Showing 1–25 of 297 awards we hold
- Germany – Pharmaceutical products – 35. Generikaausschreibung (2/3er) - Bekanntmachung vergebener Aufträge ↗GWQ ServicePlus AGshared awardawarded 25 Jul 2026
- Germany – Pharmaceutical products – 35. Generikaausschreibung (2/3er) - Bekanntmachung vergebener Aufträge ↗GWQ ServicePlus AGshared awardawarded 25 Jul 2026
- Aciclovir (CRE) ↗GWQ ServicePlus AGshared awardawarded 24 Jul 2026
- Aciclovir (CRE) ↗GWQ ServicePlus AGshared awardawarded 24 Jul 2026
- Germany – Pharmaceutical products – 35. Generikaausschreibung (1er) -Bekanntmachung der vergebenen Aufträge ↗GWQ ServicePlus AGshared awardawarded 15 Jul 2026
- 4-Hydroxybutansäure (LSE) ↗GWQ ServicePlus AGshared awardawarded 14 Jul 2026
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 16 Jun 2026
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Enalapril (ohne 2,5 mg + 5 mg), ATC C09AA02 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 May 2026
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Rivaroxaban, ATC B01AF01 für die Zeit 01.04.2026 - 30.06.2026 ↗DAK-Gesundheitshared awardawarded 2 Apr 2026
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Betahistin, ATC N07CA01 für die Zeit 01.02.26 - 31.01.28 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Feb 2026
- Germany – Pharmaceutical products – 34. Generikaausschreibung (2/3er) - Auftragsbekanntmachung ↗GWQ ServicePlus AGshared awardawarded 20 Jan 2026
- Germany – Pharmaceutical products – 34. Generikaausschreibung (Sustainability) - Auftragsbekanntmachung ↗GWQ ServicePlus AGshared awardawarded 20 Jan 2026
- Germany – Pharmaceutical products – 34. Generikaausschreibung (1er) - Auftragsbekanntmachung ↗GWQ ServicePlus AGshared awardawarded 20 Jan 2026
- Acetylcystein (RX) ↗GWQ ServicePlus AGshared awardawarded 20 Jan 2026
- Acetylcystein (OTC) ↗GWQ ServicePlus AGshared awardawarded 20 Jan 2026
- Acarbose ↗GWQ ServicePlus AGshared awardawarded 20 Jan 2026
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließlich Dafo. DOS), ATC R03AK08 für die Zeit 01.01.2026 - 31.03.2026 ↗DAK-Gesundheitshared awardawarded 1 Jan 2026
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2026 und 01.07.2026 ↗PBMG eGawarded 29 Dec 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Eisen (parenterale Zubereitungen), ATC B03AC01 f. d. Z. 01.11.25-31.10.27 (zzgl.Verlängerungsoption 1x12 Mon) ↗DAK-Gesundheitshared awardawarded 1 Nov 2025
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Eisen (parenterale Zubereitungen), ATC B03AC01 f. d. Z. 01.11.25-31.10.27 (zzgl.Verlängerungsoption 1x12 Mon) ↗DAK-Gesundheitshared awardawarded 1 Nov 2025
- Amantadin FTA - TK, hkk, HEK (ATC-Code: N04BB01) ↗Techniker Krankenkasseshared awardawarded 6 Oct 2025
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 3 Oct 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teriflunomid, ATC L04AK02 für die Zeit 01.10.2025 - 31.12.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Oct 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ticagrelor, ATC B01AC24 für die Zeit 01.06.2025 - 31.05.2027 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Oct 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dimethylfumarat (ausschl 240mg, N3), ATC L04AX07 f.d.Z. 01.10.25-30.09.27 (zzgl.Verlängerung 1x12 Mon) ↗DAK-Gesundheitshared awardawarded 2 Oct 2025
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Ratiopharm39 awards
- Ratiopharm Oy16 awards
- ratiopharm inc10 awards
- ratiopharm GmbH (BG TEVA ratiopharm GbR)8 awards
- Ratiopharm A/S7 awards
- ratiopharm GmbH [BG TEVA / ORION Pharma GbR (ratiopharm, TEVA, ORION Pharma)]2 awards
- ratiopharm GmbH (BG TEVA ratiopharm)2 awards
- ratiopharm AB1 award
- Ratiopharm (Depolabo Marseille 1)1 award
- ratiopharm GmbH (BG TEVA/Hexal GbR)1 award
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.